Lisanti Capital Growth’s Hologic HOLX Stock Holding History

Lisanti Capital Growth’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-19,630	Closed	-$891K	–	116
2017 Q2	$891K	Buy	+19,630	New	+$866K	0.59%	77

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lisanti Capital Growth's HOLX Position: Q3 2017 in Review

Lisanti Capital Growth sold out of Hologic (HOLX) in Q3 2017, closing a stake of 19,630 shares — an estimated $891K sold.

Lisanti Capital Growth first reported a position in HOLX in Q2 2017 and held it in 1 quarter. The position peaked at $891K in Q2 2017. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

Lisanti Capital Growth reported no remaining Hologic position as of Q3 2017 after selling out during the quarter.
Lisanti Capital Growth sold 19,630 Hologic shares in Q3 2017, an estimated $891K.
Lisanti Capital Growth first reported a position in Hologic in Q2 2017 and held it in 1 quarter.
Lisanti Capital Growth's Hologic position peaked at $891K in Q2 2017.
457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Lisanti Capital Growth's 13F filing for Q3 2017, filed 13 Nov 2017.